Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr418 Inhibitors

Olr418 inhibitors represent a specialized class of chemical compounds that target and modulate the activity of the Olr418 receptor, which belongs to the vast family of G-protein-coupled receptors (GPCRs). These receptors are pivotal in various physiological processes, including the detection of chemical signals, particularly in the context of olfaction, where they play a significant role in the sensory transduction pathways. The inhibition of Olr418 involves the binding of small molecules to specific sites on the receptor, leading to conformational changes that prevent the receptor from initiating its usual signal transduction cascade. This modulation is highly specific, often requiring a deep understanding of the receptor's structural biology to design or discover molecules that can precisely interact with its active or allosteric sites. The chemistry underlying these interactions can be quite complex, involving non-covalent interactions such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, all contributing to the stability and efficacy of the inhibitor-receptor complex.

From a chemical standpoint, Olr418 inhibitors can be diverse in structure, ranging from small organic molecules to more elaborate scaffolds that can mimic natural ligands or act as competitive antagonists. The design and optimization of these inhibitors often require iterative processes involving high-throughput screening, structure-activity relationship (SAR) studies, and computational modeling to refine their binding affinity and selectivity. Advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are frequently employed to elucidate the precise binding modes of these inhibitors, providing insights into the molecular dynamics of receptor inhibition. The structural diversity of Olr418 inhibitors allows for the fine-tuning of their physicochemical properties, such as solubility, stability, and permeability, which are crucial for their effectiveness in various chemical environments. Overall, Olr418 inhibitors exemplify the intricate interplay between chemistry and biology in the design of molecules capable of modulating specific receptor functions, making them a fascinating subject of study within the field of chemical biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

HMG-CoA reductase inhibitor, might modulate GPCR signaling indirectly through cholesterol biosynthesis pathways, impacting Olr418.

Bepridil

64706-54-3sc-507400
100 mg
$1620.00
(0)

Calcium channel blocker, could alter GPCR signaling indirectly by influencing calcium ion dynamics, impacting Olr418.

Fluvastatin

93957-54-1sc-279169
50 mg
$250.00
(0)

HMG-CoA reductase inhibitor, might affect GPCR signaling indirectly via lipid metabolism pathways, impacting Olr418.

Indapamide

26807-65-8sc-204777
sc-204777A
250 mg
1 g
$46.00
$64.00
(0)

Diuretic, could modulate GPCR signaling indirectly through fluid and electrolyte balance effects, impacting Olr418.

trans Lacidipine

103890-78-4sc-213066
10 mg
$153.00
(0)

Calcium channel blocker, may alter GPCR signaling indirectly through calcium ion modulation, impacting Olr418.

Rosuvastatin

287714-41-4sc-481834
10 mg
$145.00
8
(0)

HMG-CoA reductase inhibitor, can influence GPCR signaling indirectly via cholesterol regulation, impacting Olr418.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$72.00
$94.00
8
(1)

Angiotensin II receptor blocker, could indirectly affect GPCR signaling, potentially impacting Olr418.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$40.00
$92.00
$122.00
4
(1)

Angiotensin II receptor antagonist, may modulate GPCR signaling indirectly, impacting Olr418.